| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | Aug 27, 2024 | TScan Therapeutics, Inc. | Officer | Sell | 20.0 | -164,686 | -97.22% | ✗ | $952.1K |
| Sep 23, 2021 | Sep 27, 2021 | TScan Therapeutics, Inc. | Chief Legal Officer | Buy | 91.3 | +4,716 | 100.00% | ✗ | $35.3K |
| Dec 23, 2019 | Dec 30, 2019 | Dianthus Therapeutics, Inc. /DE/ | Officer | Sell | 37.5 | -12,083 | -4.24% | ✓ | $193.5K |
| Dec 24, 2019 | Dec 26, 2019 | Dianthus Therapeutics, Inc. /DE/ | Officer | Sell | 32.5 | -7,902 | -5.81% | ✓ | $126.4K |
| Dec 23, 2019 | Dec 26, 2019 | Dianthus Therapeutics, Inc. /DE/ | Officer | Sell | 41.3 | -4,181 | -2.98% | ✓ | $67K |